0
$0.00
Mini Cart
  • Empty cart

    No products in the cart.

References for Curcuma longa- TKR product

References for Curcuma longa- TKR product

– Adhvaryu MR, Reddy NM, Vakharia BC. Prevention of hepatotoxicity due to antituberculosis treatment: A novel integrative approach. World J. Gastroenterol.2008, 14(30):4753-4762.

– Aggarwal BB, Shishodia S, Takada Y, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin. Cancer Res. 2005, 11(20):7490-7498.

– Al-Jenoobi FI, Al-Thukair AA, Alam MA, Abbas FA, Al-Mohizea AM, Alkharfy KM, AlSuwayeh SA. Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects. Eur J Drug Metab Pharmacokinet. 2015 Mar; 40(1):61-6.

– Allegri P, Mastromarino A, Neri P. Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin. Ophthamol. 2010, 41-6.

– Anuchapreeda S, Leechanachai P, Smith MM et al. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol. 2002; 64:573-582.

– Appendino G, Belcaro G, Cornelli U, et al. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. Panminerva Med. 2011, 53(Suppl. 1-3):1-7.

– Appiah-Opong R, Commandeur JN, van Vugt-Lussenburg B, et al. Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology. Jun 3 2007; 235(1-2):83-91.

– Arafa HM. Uroprotective effects of curcumin in cyclophosphamide-induced haemorrhagic cystitis paradigm. Basic Clin Pharmacol Toxicol. 2009 May;104(5):393-9.

– Arora RB, Basu N, Kapoor V, et al. Indian J Med Res. 1971; 59(8):1289–1295.

– Banji D, Pinnapureddy J, Banji OJ, Kumar AR, Reddy KN. Evaluation of the concomitant use of methotrexate and curcumin on Freund’s complete adjuvant-induced arthritis and hematological indices in rats. Indian J Pharmacol. 2011 Sep; 43(5):546-50.

– Banji D, Pinnapureddy J, Banji OJ, Saidulu A, Hayath MS. Synergistic activity of curcumin with methotrexate in ameliorating Freund’s Complete Adjuvant induced arthritis with reduced hepatotoxicity in experimental animals. Eur J Pharmacol. 2011 Oct 1; 668(1-2):293-8.

– Bano G, Amla V, Raina RK, et al. The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med 1987; 53:568-9.

– Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol. 1991; 41(6):615-7.

– Basnet P, Hussain H, Tho I, Shlako-Basnet N. Liposomal delivery system enhances anti-inflammatory properties of curcumin. J Pharm Sci. 2012 Feb;101(2):598-609.

– Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol. Ther.2010, 9(1):8-14.

– Belcaro G, Cesarone MR, Dugall M, et al. Efficacy and safety of Meriva®, acurcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern. Med. Rev. 2010, 15(4):337-344.

– Belcaro G, Cesarone MR, Dugall M, et al. Product-evaluation registry of Meriva®, acurcumin-phosphatidylchole complex, for the complementary management of osteoarthritis. Panminerva Med. 2010, 52(2 Suppl 1):55-62.

–  Blaschek W, Ebel S, Hackenthal E, et al. HagerROM 2002: Hagers Handbuch der Drogen und Arzneistoffe. Heidelberg: Springer; 2002.

– Blumenthal M (ed.). The Complete German Commission E Monographs. Integrative Medicine Communications, Boston, Mass. 1998.

– Brinker F. Herb Contraindications and Drug Interactions, 4th ed. Sandy (OR): Eclectic Medical Publications; 2010.

– Carlson LJ, Cote B, Alani AW, Rao DA. Polymeric Micellar Co-delivery of Resveratrol and Curcumin to Mitigate In Vitro Doxorubicin-Induced Cardiotoxicity. J Pharm Sci. 2014 Aug;103(8):2315-22.

– Carrion-Gutierrez M, et al. Effects of Curcuma extract and visible light on adults with plaque psoriasis. Eur J Dermatol. 2015 May-Jun;25(3):240-6.

– Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phyother. Res.2012, 26:1719-1725.

– Chang HM, But PP. Pharmacology and Applications of Chinese Materia Medica, vol 2. Singapore: World Scientific; 1987. pp. 936–939.

– Chen P, Li J, Jiang HG, Lan T, Chen YC. Curcumin reverses cisplatin resistance in cisplatin-resistant lung cancer cells by inhibiting FA/BRCA pathway. Tumour Biol. 2015; 36:3591-3599.

– Chen WC, Lai YA, Lin YC, Ma JW, Huang LF, Yang NS, Ho CT, Kuo SC, Way TD. Curcumin suppresses doxorubicin-induced epithelial-mesenchymal transition via the inhibition of TGF-β and PI3K/AKT signaling pathways in triple-negative breast cancer cells. J Agric Food Chem. 2013 Dec 4; 61(48):11817.

– Chen Y, Liu WH, Chen BL, et al. Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male Chinese volunteers. Ann Pharmacother. Jun 2010; 44(6):1038-1045.

– Choi BH, Kim CG, Lim Y, Shin SY, Lee YH. Curcumin down-regulates the multidrugresistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett. 2008 Jan 18; 259(1):111-8.

– Chuengsamarn, S., Rattanamongkolgul, S., Luechapudiporn, R., Phisalaphong, C., and Jirawatnotai, S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care 2012; 35(11):2121-2127.

– Colalto C. Pharmacol Res. 2010; 62(3):207–227.

– Daveluy A, Géniaux H, Thibaud L, Mallaret M, Miremont-Salamé G, Haramburu F. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma .longa). Therapie. 2014 Nov-Dec; 69(6):519-20.

– De Smet PAGM et al. (eds.). Adverse Effects of Herb Drugs 2. Springer-Verlag, Berlin, 1993.

– Dhanasekaran S, Biswal BK, Sumantran VN, Verma RS. Augmented sensitivity to methotrexate by curcumin induced overexpression of folate receptor in KG-1 cells. Biochimie. 2013 Aug; 95(8):1567-73.

– Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem. 2007 Jul;102(2):522-38.

– Douglass BJ, Clouatre DL. Beyond Yellow Curry: Assessing Commercial Curcumin Absorption Technologies. J Am Coll Nutr. 2015; 34(4):347-58.

– Duan J, Mansour HM, Zhang Y, Deng X, Chen Y, Wang J, Pan Y, Zhao J. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles. Int J Pharm. 2012 Apr 15; 426(1-2):193-201.

– Egashira K, Sasaki H, Higuchi S, Ieiri I. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats. Drug Metab Pharmacokinet. 2012; 27(2):242- .7.

– Epelbaum R, Schaffer M, Vizel B, et al. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr. Cancer, 2010; 62(8):1137-1141.

– Ermorken AJ, Zhu J, Van de Ven WJ. Clin Cancer Res. 2010;16(7):2225.

– Farnsworth NR, Bingel AS, Cordell GA, et al. Potential value of plants as sources of new antifertility agents I. J. Pharm. Sci.1975, 64:535-598.

–  Fetoni AR, Eramo SL, Paciello F, Rolesi R, Podda MV, Troiani D, Paludetti G. Curcuma longa (curcumin) decreases in vivo cisplatin-induced ototoxicity through heme oxygenase-1 induction. Otol Neurotol. 2014 Jun; 35(5):e169-77.

– Garg SK. Planta Med. 1974; 26(3): 225–227.

– German Federal Minister of Justice. German Commission E for Human Medicine Monograph. Bundes-Anzeiger (German Federal Gazette). dated 30.11.1985, no. 223.

– Ghat BG, Srinivasan MR, Chandrasekhara N. Influence of curcumin and capsaicin on the composition and secretion of bile in rats. J. Fd. Sci. Technol.1984, 21:225-227.

– Goel A1, Aggarwal BB. Curcumin, the golden spice from Indian saffron, is achemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer. 2010; 62(7):919-30.

– Goh CL, Ng SK. Contact Derm. 1987;17(3):186.

– Govindarajan VS. Crit Rev Food Sci Nutr. 1980;12(3):199–301.

– Grill AE, KOniar B, Panyam J. Co-delivery of natural metabolic inhibitors in a selfmicroemulsifying drug delivery system for improved oral bioavailability of curcumin. Drug Deliv Transl Res. 2014 Aug; 4(4):344-352.

– Guo O, Li X, Yang Y, Wei J, Zhao Q, Luo F, Qian Z. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drugcarrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles. J Biomed Nanotechnol. 2014 Feb;10(2):227-37.

– Gupta NK, Dixit VK. Bioavailability enhancement of curcumin by complexation with phosphatidyl choline. J Pharm Sci. 2011 ay;100(5):1987-95.

– Hanai H, Iida T, Takeuchi K, et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin. Gastroenterol.Hepatol.2006, 4(12):1502-1506.

– Hata M, Sasaki E, Ota M, et al. Contact Dermatitis. 1997; 36(2):107–108.

– Hemeida RA, Mohafez OM. Curcumin attenuates methotraxate-induced hepatic oxidative damage in rats. J Egypt Natl Canc Inst. 2008 Jun; 20(2):141-8.

– Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig. Dis. Sci.2005, 50(11):2191-2193.

– Hosseinzadeh L, Behravan J, Mosaffa F, Bahrami G, Bahrami A, Karimi G. Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species. Food Chem Toxicol. 2011 May; 49(5):1102-9.

– Hou XL, Takahashi K, Tanaka K, et al. Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. Int J Pharm. Jun 24 2008; 358(1-2):224-229.

– Huq F, Yu JQ, Beale P, Chan C, Arzuman L, Nessa MU, Mazumder ME. Combinations of platinums and selected phytochemicals as a means of overcoming resistance in ovarian cancer. Anticancer Res. 2014 Jan; 34(1):541-5.

– Ibrahim MA, Elbehairy AM, Ghoneim MA, Amer HA. Protective effect of curcumin and chlorophyllin against DNA mutation induced by cyclophosphamide or benzo[a]pyrene. Z Naturforsch C. 2007 Mar-Apr; 62(3-4):215-22.

– Imbaby S, Ewais M, Essawy S, Farag N. Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats. Hum Exp Toxicol. 2014 Mar 19; 33(8):800-813.

– Jäger R, Lowery RP, Calvanese AV, Joy JM, Purpura M, Wilson JM. Comparative absorption of curcumin formulations. Nutr J. 2014 Jan 24; 13:11.

– Jantan I, Raweh SM, Sirat HM, et al. Inhibitory effect of compounds from Zingiberaceae species on human platelet aggregation. Phytomedicine. Apr 2008; 15(4):306-309.

– Juan H, Terhaag B, Cong Z, et al. Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers. Eur J Clin Pharmacol. 2007; 63(7):663–668.

– Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009 Jun;14(2):141-53.

– Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, Murakami Y, Imaizumi A, Chiba T, Nishihira J, Shibata H. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother Pharmacol. 2013 Jun; 71(6):1521-30.

– Kandarkar SV, Sawant SS, Ingle AD, et al. Indian J Exp Biol. 1998; 36(7):675–679.

– Kang HJ, Lee SH, Price JE, et al. Curcumin suppresses the paclitaxel-induced nuclear factor-kB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model. Breast J. 2009, 15(3):223-229.

– Karewicz A, Bielska D, Gzyl-Malcher B,et al. Interaction of curcumin with lipid monolayers and liposomal bilayers. Colloids Surf B Biointerfaces. 2011 Nov 1; 88(1):231-9.

– Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev. 2009 Sep;14(3):226-46.

–  Kumar B, Yadav A, Hideg K, Kuppusamy P, Teknos TN, Kumar P. A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer. PLoS One. 2014 Mar 27; 9(3):e93208.

– Kuttan R, Sudheeran PC, Joseph CD. Tumori. 1987;73:29–31.

– Lang A, Salomon N, Wu JC, Kopylov U, Lahat A, Har-Noy O, Ching JY, Cheong PK, Avidan B, Gamus D, Kaimakliotis I, Eliakim R, Ng SC, Ben-Horin S. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mildto-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2015 Feb 24.

– Liu AC, Zhao LX, Xing J, et al. Pre-treatment with curcumin enhances plasma concentrations of losartan and its metabolite EXP3174 in rats. Biol Pharm Bull. 2012, 35:145–150.

– Lucas CD, Hallagan JB, Taylor SL. Adv Food Nutr Res. 2001; 43:195–216.

– Lü YH, Yang J, Chen JC, Li LJ, Liu HX, Zheng QS. [In vitro pharmacodynamics interactions of antitumor effect of the combination of adriamycin and curcumin evaluated by the parameter method and the response surface]. Yao Xue Xue Bao. 2010 Aug; 45(8):1039-42.

– Maiti K, Mukherjee K, Gantait A, et al. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm. 2007 Feb .7; 330(1-2):155-63.

– Marczylo TH, Verschoyle RD, Cooke DN, et al. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol. 2007 Jul; 60(2):171-7.

– McGuffin M, Hobbs C, Upton R, Goldberg A (ed.). Botanical Safety Handbook. CRC Press, Boca Raton, 1997.

– Meghwal M, Goswami TK. Piper nigrum and piperine: an update. Phytother Res. 2013, Aug; 27(8):1121-30.

– Meiyanto E, Putri DD, Susidarti RA, Murwanti R, Sardjiman, Fitriasari A, Husnaa U, Purnomo H, Kawaichi M. Curcumin and its analogues (PGV-0 and PGV-1) enhance sensitivity of resistant MCF-7 cells to doxorubicin through inhibition of HER2 and NFkB activation. Asian Pac J Cancer Prev. 2014; 15(1):179-84.

– Mills & Bone – Principles and practice of Phytotherapy. Modern Herbal Medicine, 2ed. Churchill Livingstone, 2013.

– Mills S, Bone K. The Essential Guide to Herbal Safety, Elsevier Churchill Livingstone, St. Louis, 2005.

– Miquel J, Martinez M, Diez A, et al. Age. 1995;18(4):171–174.

– Misra R1, Sahoo SK. Coformulation of doxorubicin and curcumin in poly(D,L-lactideco-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm. 2011 Jun 6; 8(3):852-66.

– Mitchell TM. Correspondence re: Somasundaram et al., Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res 62:3868-3875, 2002. Cancer Res 2003; 63:5165-5166; author reply 5166-5167.

– Mohamad RH, El-Bastawesy AM, Zekry ZK, Al-Mehdar HA, Al-Said MG, Aly SS, Sharawy SM, El-Merzabani MM. The role of Curcuma longa against doxorubicin  (adriamycin)-induced toxicity in rats. J Med Food. 2009 Apr;12(2):394-402.

– Morsy MA, Ibrahim SA, Amin EF, Kamel MY, Rifaai RA, Hassan MK. Curcumin ameliorates methotrexate-induced nephrotoxicity in rats. Adv Pharmacol Sci. 2013; 2013:387071.

– Navis I, Sriganth P, Premalatha B. Dietary curcumin with cisplatin administration modulates tumour marker indices in experimental fibrosarcoma. Pharmacol Res 1999; 39:175-179.

– Notarbartolo M, Poma P, Perri D et al. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells: analysis of their possible relationship to changes in NF-κB activation levels and in IAP gene expression. Cancer Lett 2005; 224:53-65.

– Palipoch S, Punsawad C, Koomhin P, Suwannalert P. Hepatoprotective effect of curcumin and alpha-tocopherol against cisplatin-induced oxidative stress. BMC Complement Altern Med. 2014 Mar 28; 14:111.

– Patel BB, Majumdar AP. Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview. Nutr Cancer. 2009; 61(6):842-6.

– Patel BB, Sengupta R, Qazi S, Vachhani H, Yu Y, et al.: Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Int J Cancer 122, 2008, 267–273.

– Patel MK, Barvaliya MJ, Patel TK. Evaluation of the concomitant use of methotrexate and curcumin on Freund’s complete adjuvant-induced arthritis and hematological indices in rats. Indian J Pharmacol. 2012 May; 44(3):425; author reply 426.

– Patil TN, Srinivasan M. Indian J Exp Biol. 1971; 9(2):167–169.

– Pattanaik S, Hota D, Prabhakar S, et al. Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy. Phytother Res. 2006, 20: 683–686.

– Pattanaik S, Hota D, Prabhakar S, et al. Pharmacokinetic interaction of single dose of piperine with steady state carbamazepine in epilepsy patient. Phytother Res. 2009, 23: 1281–1286.

– Pavithra BH, Prakash N, Jayakumar K. Modification of pharmacokinetics of norfloxacin following oral administration of curcumin in rabbits. J Vet Sci. Dec 2009; 10(4):293-297.

– Prakash P, Misra A, Surin WR, et al. Anti-platelet effects of Curcuma oil inexperimental models of myocardial ischemia-reperfusion and thrombosis. Thromb Res. Feb 2011; 127(2):111-118.

– Pramanik D, Campbell NR, Das S, Gupta S, Chenna V, Bisht S, Sysa-Shah P, Bedja D,Karikari C, Steenbergen C, Gabrielson KL, Maitra A, Maitra A. A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy. Oncotarget. 2012 Jun; 3(6):640-50.

– Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat. 2014 Jan; 46(1):2-18.

– Punithavathi D, Venkatesan N, Babu M. Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats. Br J Pharmacol 2000; 131:169-172.

– Qian H, Yang Y, Wang X. Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy. Eur J Pharm Sci. 2011 Jun 14; 43(3):125-31.

– Qureshi S, Shah AH, Ageel AM. Planta Med. 1992; 58(2):124–127.

– Rao AJ, Kotagi SG. IRCS Med Sci. 1984; 12:500–501.

– Raucy JL. Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos. 2003; 31:533-539.

– Roy M, Mukherjee S. Reversal of resistance towards cisplatin by curcumin in cervical cancer cells. Asian Pac J Cancer Prev. 2014; 15(3):1403-10.

– Royt M, Mukherjee S, Sarkar R, Biswas J. Curcumin sensitizes chemotherapeutic drugs via modulation of PKC, telomerase, NF-kappaB and HDAC in breast cancer. Ther Deliv. 2011 Oct; 2(10):1275-93.

– Sadzuka Y, Nagamine M, Toyooka T, Ibuki Y, Sonobe T. Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin. Int J Pharm. 2012 Aug 1; 432(1-2):42-9.

– Sahdeo P, Amit K Tyagi, Bharat B Aggarwal. Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice. Cancer Res Treat 2014 Jan; 46(1):2-18.

– Sahin K, Orhan C, Tuzcu M, Muqbil I, Sahin N, Gencoglu H, Guler O, Padhye SB, Sarkar FH, Mohammad RM. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity. Biol Trace Elem Res. 2014 Feb; 157(2):156-63.

– Saleh EM, El-awady RA, Eissa NA, Abdel-Rahman WM. Antagonism between curcumin and the topoisomerase II inhibitor etoposide: a study of DNA damage, cell cycle regulation and death pathways. Cancer Biol Ther. 2012 Sep; 13(11):1058-71.

– Salehi P, Akinpelu OV, Waissbluth S, Peleva E, Meehan B, Rak J, Daniel SJ. Attenuation of Cisplatin ototoxicity by otoprotective effects of nanoencapsulated curcumin and dexamethasone in a Guinea pig model. Otol Neurotol. 2014 Aug; 35(7):1131-9.

– Sambaiah K, Ratankumar S, Kamanna VS, et al. J Food Sci Technol. 1982; 19:187–190.

– Sen GS, Mohanty S, Hossain DM, Bhattacharyya S, Banerjee S, Chakraborty J, Saha S, Ray P, Bhattacharjee P, Mandal D, Bhattacharya A, Chattopadhyay S, Das T, Sa G. Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 crosstalk in favor of p53-p300 in breast cancer. J Biol Chem. 2011 Dec 9; 286(49):42232-47.

– Shankar TNB, Shantha NV, Ramesh HP, et al. Indian J Exp Biol. 1980; 18(1):73–75.

– Shikh J, Ankola DD Beniwal V, Singh D, Kumar MN. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to Curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci. 2009 Jun 28; 37(3-4):223-30.

– Shishodia S, Chaturvedi MM, Aggarwal BB. Role of curcumin in cancer therapy. Curr. Probl. Cancer.2007, 31(4):243-305.

– Shoba G, Joy D, Joseph T. et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998 May; 64(4):353-6.

– Si M, Zhao J, Li X, Tian JG, Li YG, Li JM. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein. Chin Med J (Engl). 2013 Nov; 126(21):4116-23.

– Song WB, Zhang ZS, Xiao B. [Protective effect of curcumin against methotrexateinduced small intestinal damage in rats]. Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jan; 28(1):119-21.

–  Somasundaram S, Edmund NA, Moore DT, et al. Dietary cucumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res.2002, 62:3868-3875.

– Srimal RC, Dhawan BN. J Pharm Pharmacol. 1973; 25(6):447–452.

– Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets Prostagland. Leukotri. Ess. F. A.1995, 52:223-227.

– Srivastava KC. Extracts from two frequently consumed spices–cumin (Cuminum cyminum) and turmeric (Curcuma longa)–inhibit platelet aggregation and alter eicosanoid biosynthesis in human blood platelets. Prostaglandins Leukot Essent Fatty Acids. 1989; 37:57-64.

– Srivastava R, Dikshit M, Srimal RC, et al. Anti-thrombotic effect of curcumin. Thromb. Res.1985, 40:413-417.

– Srivastava R, Puri V, Srimal RC, et al. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis. Arzneim.-Forsch.1986, 36(4):715-717.

– Su CC, Yang JS, Lu CC, Chiang JH, Wu CL, Lin JJ, Lai KC, Hsia TC, Lu HF, Fan MJ, Chung JG. Curcumin inhibits human lung large cell carcinoma cancer tumour growth in a murine xenograft model. Phytother Res. 2010 Feb; 24(2):189-92.

– Swamy AV, Gulliaya S, Thippeswamy A, Koti BC, Manjula DV. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian J Pharmacol. 2012 Jan; 44(1):73-7.

– Tang M, Larson-Meyer DE, Liebman M. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr. May 2008; 87(5):1262-1267.

– Toden S, Okugawa Y, et al. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Carcinogenesis. 2015 Mar; 36(3):355-67.

– Ulbricht CE, Basch, EM. Natual Standard Herb & Supplement Reference: EvidenceBased Clinical Reviews St. Louis, MO: Elsevier Mosby; 2005.

– van’t Land B, Blijlevens NM, Marteijn J, Timal S, Donnelly JP, de Witte TJ, M’Rabet L. Role of curcumin and the inhibition of NF-kappaB in the onset of chemotherapyinduced mucosal barrier injury. Leukemia. 2004 Feb; 18(2):276-84.

– Velpandian T, Jasuja R, Bhardwaj RK, et al. Piperine in food: interference in the pharmacokinetics of phenytoin. Eur J Drug Metab Pharmacokinet. 2001. 26: 241–247.

– Venkatesan N, Chandrakasan G. Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 1995; 142:79-104

– Venkatesan N, Punithavathi V, Chandrakasan G. Curcumin protects bleomycin-induced lung injury in rats. Life Sci 1997; 61:PL51-58.

– Volak LP, Hanley MJ, Masse G, Hazarika S, Harmatz JS, Badmaev V, Majeed M, Greenblatt DJ, Court MH. Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers. Br J Clin Pharmacol. 2013 Feb; 75(2):450-62.

– Wahlström B, Blennow G. Acta Pharmacol Toxicol (Copenh). 1978; 43:86–92.

–  Wang H1, Hu L, Li C, Zhang J, Zhang T. Increase of therapeutic activity of doxorubicin by long circulating liposomes in combination with curcumin. Pharmazie. 2011 Nov; 66(11):871-4.

– Wang Y, Hu PC, Gao FF, Lv JW, Xu S, Kuang CC, Wei L, Zhang JW. The Protective Effect of Curcumin on Hepatotoxicity and Ultrastructural Damage Induced by Cisplatin. Ultrastruct Pathol. 2014 Jul 31:1-5.

– Waseem M, Pandey P, Tomar B, Raisuddin S, Parvez S. Ameliorative Action of Curcumin in Cisplatin-mediated Hepatotoxicity: An In Vivo Study in Wistar Rats. Arch Med Res. 2014 Jul 28.

– Wichtl M (ed.). Herbal Drugs and Phytopharmaceuticals. CRC Press, Boca Raton, 1994.

– Xiao H, Zhang KJ. [Antiproliferative effect of curcumin combined with cyclophosmide on the growth of human lymphoma cell line HT/CTX with drug resistance and its relation with FA/BRCA pathway]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008.Aug; 16(4):804-8.

– Yin H, Guo R, Xu Y, Zheng Y, Hou Z, Dai X, Zhang Z, Zheng D, Xu H. Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer. Acta Biochim Biophys Sin (Shanghai). 2012 Feb; 44(2):147-53.

– Yue GG, Cheng SW, Yu H, et al. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. J Med Food. 2012; 15:242-252.

– Yu LL, Wu JG, Dai N, Yu HG, Si JM. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor. Oncol Rep. 2011 Nov; 26(5):1197-203.

– Zhang H, Yu T, Wen L, Wang H, Fei D, Jin C. Curcumin enhances the effectiveness of cisplatin by suppressing CD133+ cancer stem cells in laryngeal carcinoma treatment. Exp Ther Med. 2013 Nov; 6(5):1317-1321.

– Zhang W, Lim LY. Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro. Drug Metab Dispos. Jul 2008; 36(7):1283-1290.

–  Zhang W, Tan TM, Lim LY. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats.Drug Metab Dispos. Jan 2007; 35(1):110-115.

– Zhu DJ, Chen XW, Wang JZ, Ju YL, Ou Yang MZ, Zhang WJ. Proteomic analysis identifies proteins associated with curcumin-enhancing efficacy of irinotecan-induced apoptosis of colorectal cancer LOVO cell. Int J Clin Exp Pathol. 2013 Dec 15; 7(1):1-15.

Leave us a comment

Cart Item Removed. Undo
  • No products in the cart.